ATE518138T1 - Stabilisierung von konjugaten mit einem thiourea- binder - Google Patents
Stabilisierung von konjugaten mit einem thiourea- binderInfo
- Publication number
- ATE518138T1 ATE518138T1 AT08020499T AT08020499T ATE518138T1 AT E518138 T1 ATE518138 T1 AT E518138T1 AT 08020499 T AT08020499 T AT 08020499T AT 08020499 T AT08020499 T AT 08020499T AT E518138 T1 ATE518138 T1 AT E518138T1
- Authority
- AT
- Austria
- Prior art keywords
- thiourea
- conjugate
- conjugates
- stabilization
- binder
- Prior art date
Links
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 title abstract 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title abstract 7
- 239000011230 binding agent Substances 0.000 title 1
- 230000006641 stabilisation Effects 0.000 title 1
- 238000011105 stabilization Methods 0.000 title 1
- 230000000087 stabilizing effect Effects 0.000 abstract 2
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07023206 | 2007-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE518138T1 true ATE518138T1 (de) | 2011-08-15 |
Family
ID=39271113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08020499T ATE518138T1 (de) | 2007-11-30 | 2008-11-26 | Stabilisierung von konjugaten mit einem thiourea- binder |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110112291A1 (enExample) |
| EP (1) | EP2065705B1 (enExample) |
| JP (1) | JP5523695B2 (enExample) |
| CN (1) | CN101445503A (enExample) |
| AT (1) | ATE518138T1 (enExample) |
| CA (1) | CA2645309C (enExample) |
| ES (1) | ES2369717T3 (enExample) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5112930A (en) * | 1975-04-08 | 1976-01-31 | Kumiai Chemical Industry Co | Anteiseiryokonaru noengeiyosakinsoseibutsu |
| JPS5718605A (en) * | 1980-07-07 | 1982-01-30 | Kumiai Chem Ind Co Ltd | Stable insecticidal composition |
| GB2095818B (en) | 1981-03-27 | 1985-10-02 | Exxon Research Engineering Co | Staged adsorption/resorption heat pump |
| JPS5855417A (ja) * | 1981-09-27 | 1983-04-01 | Nitto Electric Ind Co Ltd | 医薬組成物 |
| AU2541592A (en) * | 1991-08-01 | 1993-03-02 | Hybritech Incorporated | Improvements in or relating to modified haptens useful as imaging and therapeutic agents |
| US5541287A (en) * | 1992-06-09 | 1996-07-30 | Neorx Corporation | Pretargeting methods and compounds |
| ATE177842T1 (de) * | 1993-09-03 | 1999-04-15 | Behringwerke Ag | Fluoreszenz-sauerstoffkanalisation-immunteste |
| IT1298693B1 (it) * | 1996-04-24 | 2000-01-12 | Hoffmann La Roche | Derivati della fluoresceina 4'-metil sostituiti |
| WO2000064946A2 (en) * | 1999-04-28 | 2000-11-02 | Board Of Regents, The University Of Texas System | Compositions and methods for cancer treatment by selectively inhibiting vegf |
| US6586628B2 (en) * | 2000-05-10 | 2003-07-01 | The United States Of America, As Represented By The Secretary Of Agriculture | 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
| US6586460B1 (en) | 2001-04-02 | 2003-07-01 | The Board Of Regents For Oklahoma State University | Heteroarotinoids containing urea or thiourea linker |
| US20030171260A1 (en) * | 2002-03-11 | 2003-09-11 | Nelson Deanna Jean | Compositions and methods utilizing hydroxamates to scavenge oxidant toxins |
| US7371524B2 (en) * | 2003-06-17 | 2008-05-13 | Hannjorg Hereth | Substituted azaporphyrins as fluorescence labels |
| DE102004045748A1 (de) * | 2004-09-21 | 2006-04-06 | Roche Diagnostics Gmbh | Stöchiometrisch definierte farbstoffmarkierte Substanzen zur Messung der glomerulären Filtrationsrate, ihre Herstellung und Verwendung |
| EP1795607A1 (en) * | 2005-12-08 | 2007-06-13 | Roche Diagnostics GmbH | Stabilized cholinesterase substrate solution |
| AU2006100657C4 (en) * | 2006-05-15 | 2009-09-10 | Wyeth | Stabilised formulation |
-
2008
- 2008-11-26 ES ES08020499T patent/ES2369717T3/es active Active
- 2008-11-26 AT AT08020499T patent/ATE518138T1/de active
- 2008-11-26 US US12/323,942 patent/US20110112291A1/en not_active Abandoned
- 2008-11-26 EP EP08020499A patent/EP2065705B1/en active Active
- 2008-11-27 CA CA2645309A patent/CA2645309C/en active Active
- 2008-11-27 JP JP2008302955A patent/JP5523695B2/ja active Active
- 2008-11-28 CN CNA200810179982XA patent/CN101445503A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2645309C (en) | 2016-07-19 |
| EP2065705B1 (en) | 2011-07-27 |
| US20110112291A1 (en) | 2011-05-12 |
| CA2645309A1 (en) | 2009-05-30 |
| ES2369717T3 (es) | 2011-12-05 |
| JP5523695B2 (ja) | 2014-06-18 |
| CN101445503A (zh) | 2009-06-03 |
| JP2009132716A (ja) | 2009-06-18 |
| EP2065705A1 (en) | 2009-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE469158T1 (de) | Heteroalkylgebundene pyrimidinderivate | |
| DE602007000908D1 (de) | Härtbare wässrige Zusammensetzungen | |
| EA200800952A1 (ru) | Конъюгаты антитело-лекарство и способы применения | |
| ATE486872T1 (de) | Maleimid-derivate, pharmazeutische zusammensetzungen und verfahren zur behandlung von krebs | |
| CY1110925T1 (el) | Νεες ενωσεις | |
| CY1109696T1 (el) | Υποκατεστημενα παραγωγα πυριδινυλιου και πυριμιδινυλιου ως διαμορφωτες του μεταβολισμου και η θεραπεια των σχετικων με αυτον διαταραχων | |
| EA201001639A1 (ru) | Композиции и способы их получения и применения | |
| CO6290692A2 (es) | Agentes citotoxicos que comprenden nuevos derivados de tomaimicina y su uso terapeutico | |
| CY1115199T1 (el) | Κυτταροτοξικοι παραγοντες που περιεχουν νεα παραγωγα τομαϋμυκινης και η θεραπευτικη τους χρηση | |
| CY1118725T1 (el) | Σταθερη ενωση σιδηρου-ολιγοσακχαριτη | |
| EA200970569A1 (ru) | Применимые в качестве гербицидных соединений пиридопиразиновые производные | |
| MX2010003366A (es) | Derivados de piperidina y piperazina para el tratamiento de tumores. | |
| MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
| EA200900023A1 (ru) | Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли | |
| DK2074120T3 (da) | Tropan-forbindelser | |
| EA200870615A1 (ru) | Производные лептомицина | |
| WO2013093720A3 (en) | Anti-diabetic compounds | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| WO2007084595A3 (en) | Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors | |
| WO2009071524A3 (en) | Indolinone derivatives and process for their manufacture | |
| WO2007067597A3 (en) | Methods and compositions for needleless delivery of binding partners | |
| CY1113435T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει παραγωγο πυραζινης, και μεθοδος χρησης παραγωγου πυραζινης σε συνδυασμο | |
| WO2006100082A3 (de) | Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung | |
| BR112014014464A2 (pt) | uso de n-hidroxisuccinimida para melhorar a estabilidade do conjugado | |
| ATE530188T1 (de) | Zusammensetzungen und verfahren zur abgabe von mitteln gegen krebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2065705 Country of ref document: EP |